bismuth has been researched along with Skin Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arman, HD; Bandyopadhyay, D; Banik, BK; Cruz, J; Cuate, E; Kim, DJ; Lee, YS; Morales, LD | 1 |
Allen, BJ; Graham, P; Kearsley, J; Li, Y; Qu, CF; Raja, C; Rizvi, S; Song, E; Thompson, J; Tsui, W; Zhang, D | 1 |
Allen, BJ; Graham, P; Kearsley, J; Li, Y; Raja, C; Reisfeld, RA; Rizvi, S; Thompson, JF; Tsui, W | 1 |
Allen, BJ; Graham, P; Raja, C; Rizvi, S; Song, EY | 1 |
Allen, BJ; Rizvi, SM; Tian, Z | 1 |
Yannoulis, GE | 1 |
1 trial(s) available for bismuth and Skin Neoplasms
Article | Year |
---|---|
Intralesional targeted alpha therapy for metastatic melanoma.
Topics: Aged; Aged, 80 and over; Alpha Particles; Antibodies, Bispecific; Antibodies, Monoclonal; Biomarkers, Tumor; Bismuth; Female; Half-Life; Humans; Immunoconjugates; Injections, Intralesional; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Tissue Distribution | 2005 |
5 other study(ies) available for bismuth and Skin Neoplasms
Article | Year |
---|---|
A green approach toward quinoxalines and bis-quinoxalines and their biological evaluation against A431, human skin cancer cell lines.
Topics: Bismuth; Catalysis; Cell Line; Cell Survival; Crystallography, X-Ray; Green Chemistry Technology; Humans; Microwaves; Molecular Conformation; Nitrates; Phosphorylation; Quinoxalines; Skin Neoplasms; STAT3 Transcription Factor | 2013 |
Targeted alpha therapy for cancer.
Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Apoptosis; Bismuth; Cell Line, Tumor; Chelating Agents; Clinical Trials as Topic; Female; Flow Cytometry; Humans; Kinetics; Male; Melanoma; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Prostatic Neoplasms; Radioisotopes; Radiotherapy; Sensitivity and Specificity; Skin Neoplasms; Time Factors | 2004 |
Tumour anti-vascular alpha therapy: a mechanism for the regression of solid tumours in metastatic cancer.
Topics: Alpha Particles; Bismuth; Clinical Trials as Topic; Dose-Response Relationship, Radiation; Humans; Kinetics; Melanoma; Neoplasm Metastasis; Radioisotopes; Radiotherapy; Skin Neoplasms; Time Factors; Treatment Outcome | 2007 |
Preclinical targeted alpha therapy for subcutaneous melanoma.
Topics: Animals; Bismuth; Body Weight; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Humans; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Radioisotopes; Skin Neoplasms; Time Factors; Tissue Distribution | 2001 |
[Proceedings: Keratoacanthosis].
Topics: Adult; Aged; Bismuth; Female; Humans; Keratoacanthoma; Male; Middle Aged; Radiography; Skin Neoplasms; Suppositories; Time Factors | 1973 |